Differences

This shows you the differences between two versions of the page.

--- home:diseases:cancer [05.16.2019] – [Other Immune Suppressants] sallieq
+++ home:diseases:cancer [05.16.2019] – [Other Immune Suppressants] sallieq
@@ Line 100: / Line 100: @@
-Women with hereditary breast cancer predispositions should avoid using their smartphones, tablets, and laptops at night.   (({{pubmed>long:    29456806}}))
+Women with hereditary cancer predispositions should put their smartphones, tablets, and laptops into air-plane mode at all times when not in use.   (({{pubmed>long:    29456806}}))
 Glioblastomas and malignant gliomas are the most common primary malignant brain tumors, with an annual incidence of 5.26 per 100,000 population. These tumors are typically associated with a dismal prognosis and poor quality of life. Only radiation exposure and certain genetic syndromes are well-defined risk factors for malignant glioma.   (({{pubmed>long:    24193082}}))
@@ Line 374: / Line 374: @@
 ===== Recent research =====
 Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner.  (({{pubmed>long:30104241}}))
 {{section>:home:pathogenesis:innate_immunity#recent_research_into_valuable_proteins&noheader}}
 Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer. (({{pubmed>long:30579121}}))
-This compound has antiproliferative and antimigratory effects in squamous cell carcinoma, glioblastoma, and breast cancer cell lines (({{pubmed>long:    31025400}}))
 Olmesartan and Bay11-7082 inhibit the MCF-7 cells growth indicating RAS and NF-kappaB pathway blockade lead to cytotoxicity and apoptosis induction against tumour cells. So ARBs and NF-kappaB pathway inhibitors could be considered as anticancer drugs in future.  (({{pubmed>long:26138656}}))

home/diseases/cancer.txt · Last modified: 09.14.2022 by 127.0.0.1